Skip to main content
Peter Traber, MD, Internal Medicine, Houston, TX

PeterGTraberMD

Internal Medicine Houston, TX

Gastroenterology

Physician

Dr. Traber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Traber's full profile

Already have an account?

  • Office

    6620 Main St
    Houston, TX 77030
    Phone+1 713-798-2500
    Fax+1 713-798-2505

Education & Training

  • University of Michigan
    University of MichiganFellowship, Gastroenterology, 1986 - 1987
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Gastroenterology, 1984 - 1985
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1981 - 1984
  • Wayne State University School of Medicine
    Wayne State University School of MedicineClass of 1981

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1993
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes on Long-Term Migraine Drug Data, Decision Day for Eton, 2 IPOs
    The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes on Long-Term Migraine Drug Data, Decision Day for Eton, 2 IPOsMay 27th, 2021
  • Selecta Biosciences, Inc. (SELB) Q3 2020 Earnings Call Transcript
    Selecta Biosciences, Inc. (SELB) Q3 2020 Earnings Call TranscriptNovember 6th, 2020
  • Innovate Biopharmaceuticals Plans to Commence the First Ever Phase 3 Registration Trial in Celiac Disease in 1H 2019 and Announce Top-Line NASH Data with Drug Combinations by EASL 2019
    Innovate Biopharmaceuticals Plans to Commence the First Ever Phase 3 Registration Trial in Celiac Disease in 1H 2019 and Announce Top-Line NASH Data with Drug Combinations by EASL 2019December 17th, 2018
  • Join now to see all

Grant Support

  • Regulation Of Intestine-Specific Gene TranscriptionNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2001
  • Core--Morphology FacilityNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2001
  • Molecular Mechanisms Of Intestinal DevelopmentNational Institute Of Diabetes And Digestive And Kidney Diseases1995–2001
  • Caudal-Related Genes In Mouse Intestinal DevelopmentNational Institute Of Diabetes And Digestive And Kidney Diseases1996–2000
  • Center For Digestive And Liver DiseasesNational Institute Of Diabetes And Digestive And Kidney Diseases1997–1999
  • Training Program In Gastrointestinal SciencesNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1998
  • GI Tract Conf--Development, Differentiation, AdaptationNational Institute Of Diabetes And Digestive And Kidney Diseases1997
  • Homeodomain Genes In Intestinal DevelopmentNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1997
  • Regulation Of Intestine Specific Gene TranscriptionNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1996
  • University Of Pennsylvania Training In GastroenterologyNational Institute Of Diabetes And Digestive And Kidney Diseases1993–1994
  • Intestinal And Colonic Cytochrome P450 Gene ExpressionNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1993
  • Intestinal And Colonic Cytochrome P450 Gene ExpressionNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1992